IRS4 and cancer: IRS-4 is an adaptor protein acting as a constitutive activator of critical cell transduction pathways in cancer, leading to the activation of the PI3K/Akt pathway collaborating with the actions of the human epidermal growth factor receptor 2 (HER2) [13].